1. Home
  2. TANH vs ARTL Comparison

TANH vs ARTL Comparison

Compare TANH & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$1.02

Market Cap

3.2M

Sector

N/A

ML Signal

HOLD

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.95

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
ARTL
Founded
2001
2011
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
ARTL
Price
$1.02
$1.95
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$30.00
AVG Volume (30 Days)
40.6K
1.2M
Earning Date
01-02-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$42,940,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$1.52
52 Week High
$10.77
$28.60

Technical Indicators

Market Signals
Indicator
TANH
ARTL
Relative Strength Index (RSI) 34.80 42.42
Support Level $1.02 $1.69
Resistance Level $1.13 $1.94
Average True Range (ATR) 0.07 0.20
MACD 0.01 0.11
Stochastic Oscillator 25.47 76.76

Price Performance

Historical Comparison
TANH
ARTL

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: